Haoxi Health Technology Limited Class A(HAO)
$1.86-0.07 (-3.89%)
HAO
Haoxi Health Technology Limited Class A financials statements
$1.86
At close:-0.07 (-3.89%)
Want to see HAO full AI Analyst Report?
Haoxi Health Technology Limited Class A (HAO) Ratios
103 Followers
Haoxi Health Technology Limited Class A Ratios
HAO's free cash flow for Q4 2026 was $-301.83K. For the 2026 fiscal year, HAO's free cash flow was increased by $0.00 and operating cash flow was $-301.83K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.53 | 5.05 | 3.98 | 1.43 | 0.22 |
| Quick Ratio | 4.53 | 5.05 | 2.64 | 0.49 | 0.22 |
| Cash Ratio | 2.95 | 2.22 | 1.72 | 0.47 | 0.15 |
| Solvency Ratio | -2.47 | 1.01 | 0.31 | 0.34 | 0.12 |
| Operating Cash Flow Ratio | -0.69 | -0.86 | -0.19 | -0.34 | -0.34 |
| Short-Term Operating Cash Flow Coverage | -1.59 | -1.99 | -0.90 | -1.71 | -1.54 |
| Net Current Asset Value | $ 13.10M | $ 15.39M | $ 11.15M | $ 776.37K | $ -1.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.09 | 0.08 | 0.19 | 0.93 |
| Debt-to-Equity Ratio | 0.09 | 0.11 | 0.11 | 0.54 | -0.34 |
| Debt-to-Capital Ratio | 0.08 | 0.10 | 0.10 | 0.35 | -0.53 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.02 | 0.03 | 0.14 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.24 | 1.38 | 2.85 | -0.37 |
| Debt Service Coverage Ratio | -4.69 | 2.48 | 1.54 | 1.88 | 0.57 |
| Interest Coverage Ratio | -155.59 | -43.52 | 41.69 | 57.21 | 26.98 |
| Debt to Market Cap | 63.42 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1348.92 | 17.49 | 0.10 | 0.08 | 0.05 |
| Net Debt to EBITDA | 1.20 | -1.45 | -3.05 | -0.29 | 0.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 1.15% | 2.83% | 5.67% | 7.30% | 4.02% |
| EBIT Margin | -14.88% | 12.78% | 3.66% | 4.29% | 1.67% |
| EBITDA Margin | -14.17% | 13.92% | 3.68% | 4.32% | 1.68% |
| Operating Profit Margin | -14.88% | -6.10% | 3.54% | 4.24% | 1.66% |
| Pretax Profit Margin | -17.33% | 12.64% | 3.58% | 4.22% | 1.61% |
| Net Profit Margin | -17.39% | 11.82% | 2.66% | 3.44% | 1.51% |
| Continuous Operations Profit Margin | -17.39% | 11.82% | 2.66% | 3.44% | 1.51% |
| Net Income Per EBT | 100.39% | 93.47% | 74.44% | 81.46% | 94.22% |
| EBT Per EBIT | 116.42% | -207.38% | 101.05% | 99.55% | 96.59% |
| Return on Assets (ROA) | -44.21% | 17.95% | 8.33% | 21.72% | 45.04% |
| Return on Equity (ROE) | -53.40% | 22.31% | 11.46% | 61.91% | -16.69% |
| Return on Capital Employed (ROCE) | -45.69% | -11.29% | 14.75% | 63.35% | -18.34% |
| Return on Invested Capital (ROIC) | -41.91% | -9.64% | 10.29% | 39.14% | -26.37% |
| Return on Tangible Assets | -44.21% | 19.59% | 8.33% | 21.72% | 45.04% |
| Earnings Yield | -37514.14% | 1.00% | 0.08% | 0.07% | 0.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 405.45 | 6.21 | 13.67 | 426.28 | 4125.86 |
| Payables Turnover | 338.57 | 207.17 | 70.02 | 956.96 | 12.20 |
| Inventory Turnover | 0.00 | 0.00 | 8.85 | 10.88 | 0.00 |
| Fixed Asset Turnover | 526.35 | 174.41 | 382.82 | 120.96 | 164.97 |
| Asset Turnover | 2.54 | 1.52 | 3.13 | 6.32 | 29.76 |
| Working Capital Turnover Ratio | 3.80 | 2.41 | 7.69 | -121.15 | -8.95 |
| Cash Conversion Cycle | -0.18 | 57.06 | 62.75 | 34.02 | -29.84 |
| Days of Sales Outstanding | 0.90 | 58.82 | 26.70 | 0.86 | 0.09 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 41.26 | 33.54 | 0.00 |
| Days of Payables Outstanding | 1.08 | 1.76 | 5.21 | 0.38 | 29.93 |
| Operating Cycle | 0.90 | 58.82 | 67.97 | 34.40 | 0.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2081.41 | -28.77 | -0.06 | -0.08 | -0.07 |
| Free Cash Flow Per Share | -2081.41 | -28.77 | -0.07 | -0.08 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -856152.33 | -1679041.00 | -13.50 | -19.17 | -77.65 |
| Capital Expenditure Coverage Ratio | -856152.33 | -1679041.00 | -13.50 | -19.17 | -77.65 |
| Operating Cash Flow Coverage Ratio | -1.59 | -1.68 | -0.62 | -1.03 | -1.34 |
| Operating Cash Flow to Sales Ratio | -0.05 | -0.10 | -0.02 | -0.03 | -0.04 |
| Free Cash Flow Yield | -10103.93% | -0.86% | -0.05% | -0.06% | -0.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.00 | 100.24 | 1215.31 | 1503.46 | 5396.85 |
| Price-to-Sales (P/S) Ratio | 0.00 | 11.84 | 32.35 | 51.65 | 81.70 |
| Price-to-Book (P/B) Ratio | 0.00 | 22.35 | 139.26 | 930.72 | -900.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.01 | -115.66 | -1955.03 | -1588.85 | -1929.66 |
| Price-to-Operating Cash Flow Ratio | -0.01 | -115.66 | -2099.83 | -1671.75 | -1954.51 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 1.77 | 1.10 | 5.64 | -269.84 |
| Enterprise Value Multiple | 1.20 | 83.63 | 875.39 | 1195.07 | 4857.83 |
| Enterprise Value | -9.30M | 381.78M | 1.56B | 1.46B | 1.32B |
| EV to EBITDA | 1.20 | 83.63 | 875.39 | 1195.07 | 4857.83 |
| EV to Sales | -0.17 | 11.64 | 32.24 | 51.64 | 81.71 |
| EV to Free Cash Flow | 3.62 | -113.69 | -1948.24 | -1588.47 | -1929.97 |
| EV to Operating Cash Flow | 3.62 | -113.69 | -2092.53 | -1671.34 | -1954.82 |
| Tangible Book Value Per Share | 14473.00 | 133.44 | 0.92 | 0.14 | -0.15 |
| Shareholders’ Equity Per Share | 14473.00 | 148.89 | 0.92 | 0.14 | -0.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.07 | 0.26 | 0.19 | 0.06 |
| Revenue Per Share | 44431.79 | 281.08 | 3.96 | 2.56 | 1.62 |
| Net Income Per Share | -7727.91 | 33.22 | 0.11 | 0.09 | 0.02 |
| Tax Burden | 1.00 | 0.93 | 0.74 | 0.81 | 0.94 |
| Interest Burden | 1.16 | 0.99 | 0.98 | 0.98 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| SG&A to Revenue | 0.16 | 0.09 | 0.02 | 0.03 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.27 | -0.87 | -0.58 | -0.90 | -2.76 |
Currency in USD
